NO116851B - - Google Patents
Download PDFInfo
- Publication number
- NO116851B NO116851B NO163654A NO16365466A NO116851B NO 116851 B NO116851 B NO 116851B NO 163654 A NO163654 A NO 163654A NO 16365466 A NO16365466 A NO 16365466A NO 116851 B NO116851 B NO 116851B
- Authority
- NO
- Norway
- Prior art keywords
- ester
- pyridine
- atom
- compound
- formula
- Prior art date
Links
- 150000002148 esters Chemical class 0.000 claims description 14
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- -1 3-pyridylcarbinol ester Chemical class 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 5
- LVPMIMZXDYBCDF-UHFFFAOYSA-N isocinchomeronic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)N=C1 LVPMIMZXDYBCDF-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 239000012433 hydrogen halide Substances 0.000 claims description 2
- 229910000039 hydrogen halide Inorganic materials 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 239000002516 radical scavenger Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 150000003512 tertiary amines Chemical class 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000000304 vasodilatating effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229960004738 nicotinyl alcohol Drugs 0.000 description 2
- CNQCWYFDIQSALX-UHFFFAOYSA-N 3-(chloromethyl)pyridine Chemical compound ClCC1=CC=CN=C1 CNQCWYFDIQSALX-UHFFFAOYSA-N 0.000 description 1
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- RWEWEOKGGLQXPR-UHFFFAOYSA-N pyridine-2,5-dicarbonyl chloride Chemical compound ClC(=O)C1=CC=C(C(Cl)=O)N=C1 RWEWEOKGGLQXPR-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE08480/65A SE336334B (cs) | 1965-06-28 | 1965-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO116851B true NO116851B (cs) | 1969-06-02 |
Family
ID=20274189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO163654A NO116851B (cs) | 1965-06-28 | 1966-06-27 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3403160A (cs) |
| AT (1) | AT260931B (cs) |
| BE (1) | BE683174A (cs) |
| BR (1) | BR6680618D0 (cs) |
| CH (1) | CH470390A (cs) |
| DE (1) | DE1645916B1 (cs) |
| DK (1) | DK116942B (cs) |
| ES (1) | ES328896A1 (cs) |
| FI (1) | FI46958C (cs) |
| FR (1) | FR5763M (cs) |
| GB (1) | GB1077850A (cs) |
| IL (1) | IL25938A (cs) |
| NL (1) | NL6608903A (cs) |
| NO (1) | NO116851B (cs) |
| SE (1) | SE336334B (cs) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT163742B (de) * | 1946-06-04 | 1949-08-10 | Hoffmann La Roche | Verfahren zur Herstellung von Estern des Pyridyl-3-carbinols |
-
1965
- 1965-06-28 SE SE08480/65A patent/SE336334B/xx unknown
-
1966
- 1966-06-09 IL IL25938A patent/IL25938A/en unknown
- 1966-06-15 DE DE19661645916 patent/DE1645916B1/de active Pending
- 1966-06-16 AT AT574366A patent/AT260931B/de active
- 1966-06-17 FI FI661625A patent/FI46958C/fi active
- 1966-06-20 GB GB27514/66A patent/GB1077850A/en not_active Expired
- 1966-06-20 CH CH891366A patent/CH470390A/de not_active IP Right Cessation
- 1966-06-22 BR BR180618/66A patent/BR6680618D0/pt unknown
- 1966-06-22 US US559400A patent/US3403160A/en not_active Expired - Lifetime
- 1966-06-25 ES ES0328896A patent/ES328896A1/es not_active Expired
- 1966-06-27 NO NO163654A patent/NO116851B/no unknown
- 1966-06-27 NL NL6608903A patent/NL6608903A/xx unknown
- 1966-06-27 FR FR67086A patent/FR5763M/fr not_active Expired
- 1966-06-27 BE BE683174D patent/BE683174A/xx unknown
- 1966-06-28 DK DK334166AA patent/DK116942B/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK116942B (da) | 1970-03-02 |
| FI46958C (fi) | 1973-08-10 |
| ES328896A1 (es) | 1967-05-01 |
| BE683174A (cs) | 1966-12-01 |
| FR5763M (cs) | 1968-02-05 |
| FI46958B (cs) | 1973-05-02 |
| AT260931B (de) | 1968-03-25 |
| BR6680618D0 (pt) | 1973-05-24 |
| NL6608903A (cs) | 1966-12-29 |
| CH470390A (de) | 1969-03-31 |
| IL25938A (en) | 1970-06-17 |
| DE1645916B1 (de) | 1971-05-19 |
| SE336334B (cs) | 1971-07-05 |
| US3403160A (en) | 1968-09-24 |
| GB1077850A (en) | 1967-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1287748A3 (ru) | Способ получени арилоксипропаноламинов или их фармакологически приемлемых солей (его варианты) | |
| JPS59501409A (ja) | ピリドン化合物 | |
| EP0249950B1 (en) | Aromatic compounds | |
| JPS62149662A (ja) | Ｎ−含有複素環化合物 | |
| NO116851B (cs) | ||
| CA3030309C (en) | Compositions for the treatment of pulmonary fibrosis | |
| DE69311129T2 (de) | Tartronsäure, deren acetalische äther und-o-ester | |
| DE949742C (de) | Verfahren zur Herstellung von N-Allylnormorphin aus Normorphin und Allylhalogenid | |
| EP0214437B1 (de) | Verfahren zur Herstellung von 1,4-Dihydropyridinderivaten über neue Zwischenprodukte | |
| EP2502916A1 (en) | Organic dicarboxylic acids, salts and preparation method thereof | |
| JPS635025B2 (cs) | ||
| JP6586692B2 (ja) | 新規キノン誘導体およびそれを有効成分とする抗トリパノソーマ剤 | |
| US4275068A (en) | Lipid lowering alkylene glycols and ester derivatives thereof | |
| US2439818A (en) | Substituted esters of benzoic acid | |
| US2374367A (en) | Process for preparing therapeutically active substances | |
| US2322375A (en) | Process for preparing therapeutically active substances | |
| JPS62169790A (ja) | ジヒドロピリジンラクト−ル類 | |
| CN115785057B (zh) | 一种替卡格雷中间化合物及其盐的制备方法 | |
| US2030373A (en) | Derivatives of thiazole and process of preparing the same | |
| US3468889A (en) | O-and/or s-nicotinoyl diacylthiamines and acylation process for preparing the same | |
| KR810001697B1 (ko) | 이소부티라미드 유도체의 신규한 제조방법 | |
| KR800000813B1 (ko) | 몰포리논 유도체의 제조법 | |
| US2337572A (en) | Medicinal compound | |
| KR810000481B1 (ko) | 치환 n-(카르복시메틸)-3-아미노프로판-2-올의 제조방법 | |
| US2798073A (en) | Piperidine derivatives and preparation |